卡介苗主动免疫疗法治疗复发性恶性黑色素瘤。 - Suppr

Active immunotherapy with B.C.G. for recurrent malignant melanoma.

作者信息

Gutterman J U, Mavligit G, McBride C, Frei E, Freireich E J, Hersh E M

出版信息

Lancet. 1973 Jun 2;1(7814):1208-12. doi: 10.1016/s0140-6736(73)90526-6.

DOI:10.1016/s0140-6736(73)90526-6

PMID:4122562

Abstract

摘要

相似文献

Active immunotherapy with B.C.G. for recurrent malignant melanoma.

Lancet. 1973 Jun 2;1(7814):1208-12. doi: 10.1016/s0140-6736(73)90526-6.

Delayed cutaneous sensitivity reactions to extracts of autologous malignant melanoma: a second look.

J Natl Cancer Inst. 1972 Jan;48(1):17-24.

Immunotherapy in patients with melanoma.

Ann Surg. 1973 Sep;178(3):352-9. doi: 10.1097/00000658-197309000-00015.

Results of administering B.C.G. to patients with melanoma.

Lancet. 1974 Nov 9;2(7889):1096-100. doi: 10.1016/s0140-6736(74)90867-8.

Adjuvant immunotherapy with BCG in treatment of regional-lymph-node metastases from malignant melanoma.

N Engl J Med. 1976 Jan 29;294(5):237-40. doi: 10.1056/NEJM197601292940501.

Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.

Gan. 1975 Aug;66(4):355-63.

[Immunological reactions of skin melanoma patients to nonspecific and adaptive immunotherapy].

Vopr Onkol. 1977;23(8):27-33.

Adoptive transfer and specific active immunization of patients with malignant melanoma.

Ann N Y Acad Sci. 1976;277(00):522-32. doi: 10.1111/j.1749-6632.1976.tb41726.x.

B.C.G. in malignant melanoma.

Lancet. 1973 May 19;1(7812):1117-8. doi: 10.1016/s0140-6736(73)90423-6.

Failure of adjuvant immunotherapy to prevent central nervous system metastases in malignant melanoma patients.

J Surg Oncol. 1977;9(2):147-53. doi: 10.1002/jso.2930090208.

引用本文的文献

Genetic Variants in Immune Related Genes as Predictors of Responsiveness to BCG Immunotherapy in Metastatic Melanoma Patients.

Cancers (Basel). 2020 Dec 30;13(1):91. doi: 10.3390/cancers13010091.

Melanocytic nevi and melanoma: unraveling a complex relationship.

Oncogene. 2017 Oct 19;36(42):5771-5792. doi: 10.1038/onc.2017.189. Epub 2017 Jun 12.

Mycobacterium bovis BCG promotes tumor cell survival from tumor necrosis factor-α-induced apoptosis.

Mol Cancer. 2014 Sep 11;13:210. doi: 10.1186/1476-4598-13-210.

Oncolytic viruses.

Invest New Drugs. 1999;17(4):375-86. doi: 10.1023/a:1006334404767.

Immunotherapy of a plasmacytoma with attenuated salmonella.

Med Oncol. 1995 Jun;12(2):103-8. doi: 10.1007/BF01676710.

Adjuvant BCG immunotherapy for malignant melanoma.

Can Med Assoc J. 1984 Oct 1;131(7):744-8.

Adjuvant BCG immunotherapy for stage I and II malignant melanoma.

Can Med Assoc J. 1983 Jun 1;128(11):1291-5.

Randomized controlled trial of adjuvant chemoimmunotherapy with DTIC and BCG after complete excision of primary melanoma with a poor prognosis or melanoma metastases.

Can Med Assoc J. 1983 Apr 15;128(8):929-33.

Current status of immunotherapy of human cancers: leukaemias, lymphomas, solid tumours.

Drugs. 1974;8(6):411-6. doi: 10.2165/00003495-197408060-00004.

Current status of immunotherapy.

Drugs. 1974;8(6):405-7. doi: 10.2165/00003495-197408060-00002.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Active immunotherapy with B.C.G. for recurrent malignant melanoma.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献